Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by elgin1on Jan 15, 2021 6:30pm
342 Views
Post# 32311777

RE:SVA can eventually be a $5.00 stock.

RE:SVA can eventually be a $5.00 stock.
rixpix wrote: If future results come in just as good or better than today's, Sernova will become a billion dollar company.

GLTA


Ripix , 

Sernova will be at a minimum $1 Billion US which is $6 a share fully diluted .  If it gets on Nasdaq I think $20 is not out of the question which is $3 Billion valuation which still might be undervaluing . Too bad you sold at 71 cents , sell $5 I bet it goes to $10. I am looking at market size of potential indications ( does not include Hemophilia , Thyroid , Immunotherapy) compariibles future potential earnings relative to market capital.

You will really see movement when Sva gets listed on Nasdaq. Look at at Trilium as a comparable.

I think you see upside next week and as more linical results are announced.

Elgin 

ps Hey Wally

<< Previous
Bullboard Posts
Next >>